During COVID-19, UC San Diego Health expanded telehealth to provide patients with safe and convenient access to appointments with their health care providers. Video visits expanded by more than 50-fold.
UC San Diego researchers have identified small molecules in the blood of asymptomatic pregnant women that may predict risk for preeclampsia, responsible for a significant proportion of maternal and neonatal deaths, low birth weight and is a primary cause of premature birth.
Study finds that microRNA biomarkers in asymptomatic pregnant women might reveal higher risk for the common and serious pregnancy complication; early identification could lead to prevention and better maternal and newborn outcomes
The NIH has launched a major clinical trial to assess the malaria drug hydroxychloroquine and antibiotic azithromycin as a treatment for COVID-19. The trial will recruit 2,000 participants at 30 sites. A QandA with the trial’s team leader: Davey Smith, MD, of UC San Diego School of Medicine.
